Botanical species · safety record
Woodfordia fruticosa
The EFSA Compendium of Botanicals holds 15 constituent measurements and 1 adverse-effect record for Woodfordia fruticosa. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.
Accepted name in source: Woodfordia fruticosa (L.) Kurz
Regulatory presence
Health Canada's Licensed Natural Health Products Database holds 3 licensed products naming Woodfordia fruticosa as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.
Extract types on licence
Source material stated
What the records describe
Constituents measured
- Tannins3
- Alkaloids2
- Anthraquinones2
- Saponins2
- Cardiac glycosides1
- Chrysophanol1
- Ellagitannins (hydrolysable tannins)1
- Epoxides1
- Gallic acid1
- Phlobotannins1
Plant parts
- Unspecified6
- Leaves5
- Flower4
- Fruit unspecified1
Preparations
- Solvent extraction16
Effect types
- Reproductive1
Target tissues
- Uterus1
Recorded constituents
What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.
| Substance | Plant part | Preparation | Concentration | Analytical method | Source |
|---|---|---|---|---|---|
| Ellagitannins (hydrolysable tannins) | Flower | Solvent extraction | — | Standard Chromatographic tests (paper- thin layer- and column chromatography) | Resolve DOI |
| Alkaloids | Leaves | Solvent extraction | 0.06 Percent | Unspecified | No resolvable identifier |
| Alkaloids | Unspecified | Solvent extraction | 1.036 Percent | Phytochemical screening | No resolvable identifier |
| Anthraquinones | Unspecified | Solvent extraction | — | Phytochemical screening | No resolvable identifier |
| Anthraquinones | Leaves | Solvent extraction | — | Phytochemical screening | No resolvable identifier |
| Cardiac glycosides | Unspecified | Solvent extraction | — | Phytochemical screening | No resolvable identifier |
| Chrysophanol | Flower | Solvent extraction | — | Standard Chromatographic tests (paper- thin layer- and column chromatography) | No resolvable identifier |
| Epoxides | Leaves | Solvent extraction | 5.43 Percent Area | Phytochemical screening | No resolvable identifier |
| Gallic acid | Flower | Solvent extraction | — | Colorimetry, Spectroscopy (Spectrometry) and Photometry | No resolvable identifier |
| Phlobotannins | Unspecified | Solvent extraction | — | Phytochemical screening | No resolvable identifier |
| Saponins | Unspecified | Solvent extraction | 3.83 Percent | Phytochemical screening | No resolvable identifier |
| Saponins | Leaves | Solvent extraction | — | Phytochemical screening | No resolvable identifier |
| Tannins | Unspecified | Solvent extraction | 14.16 Percent | Phytochemical screening | No resolvable identifier |
| Tannins | Leaves | Solvent extraction | — | Phytochemical screening | No resolvable identifier |
| Tannins | Flower | Solvent extraction | — | Gelpermeation, High Performance Thin Layer Chromatography (HPTLC) | No resolvable identifier |
Recorded adverse effects
Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.
| Effect | Target tissue | Plant part | Preparation | Test organism | Test type | Source |
|---|---|---|---|---|---|---|
| Reproductive | Uterus | Fruit unspecified | Solvent extraction | Rat (as animal) | Reproduction toxicity | No resolvable identifier |
Cited sources
The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.
- Khan, Amir Muhammad., Qureshi, Rizwana Aleem., Ullah, Faizan., Gilani, Syed Aneel., Nosheen, Asia., Sahreen, Sumaira., Laghari, Muhammad Khan., Laghari, Muhammad Yousif., Shafiq-Ur-Rehman., Hussain, Ishtiaq., et al. Phytochemical analysis of selected medicinal plants of Margalla Hills and surroundings. Journal of Medicinal Plants Research, 2011, p. 6017-6023.
- Paris, R. R., Jacquemin, H. A Madagascan Lithraceae, Woodfordia fruticosa (L.) Kurz. Communication XVIII on Madagascan plants. Fitoterapia, 1976, p. 51-55.
- Grover, N., Patni, V. Phytochemical characterization using various solvent extracts and GC-MS analysis of methanolic extract of Woodfordia fruticosa (L.) Kurz. leaves. International Journal of Pharmacy and Pharmaceutical Sciences, 2013, vol. 5, no. 4, p. 291-295.
- Khushalani, Heeshma., Tatke, Pratima., Singh, Kamalinder K. Antifertility activity of dried flowers of Woodfordia fruticosa Kurz. Indian Journal of Pharmaceutical Sciences, 2006, vol. 68, no. 4, p. 528-529.
- Bhatt, Lok Ranjan., yugcannam., coehwajeong., Baek, Seung-Hwa. Radical Scavenging Activity of Gallic Acid from Woodfordia Fruticosa Flowers. Korean Journal of Oriental Physiology & Pathology, 2008, vol. 22, no. 4, p. 903-906.
- OKUDA, T., YOSHIDA, T., HATANO, T., MORI, K., FUKUDA, T. FRACTIONATION OF PHARMACOLOGICALLY ACTIVE-PLANT POLYPHENOLS BY CENTRIFUGAL PARTITION CHROMATOGRAPHY . Journal of liquid chromatography, 1990, vol. 13, no. 18, p. 3637-3650. DOI
- CHAUHAN, JS., SRIVASTAVA, SK., SRIVASTAVA, SD. PHYTOCHEMICAL INVESTIGATION OF THE FLOWERS OF WOODFORDIA-FRUTICOSA. PLANTA MEDICA, 1979, vol. 36, no. 2, p. 183-184.
Boundary
A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.
Continue
Europe PMC
Every record indexed for this species, resolvable and re-runnable.
All speciesSubstance index
Search and browse every species this world holds under source and hash.
Before anything elseSafety Centre
Interactions, contraindications and the escalation boundary this world does not cross.
In its own termsTraditions
How the living traditions approach preparation, use and context.